CVE-2026-49225 givanz CVE debrief

Who should care

Defenders responsible for Vvveb CMS deployments, particularly those with multiple vendors or users with low-privileged access, should assess exposure and prioritize patching to prevent unauthorized access to product revisions and potential corruption of live product content.

Why it matters

CVE-2026-49225 is a high-severity vulnerability in Vvveb CMS that allows low-privileged vendors to access and manipulate product revisions belonging to other vendors, potentially leading to unauthorized access, corruption, and removal of audit history. Defenders should prioritize patching to version 1.0.8.4 or later and monitor for suspicious activity.

• Potential unauthorized access to sensitive product content
• Possible corruption of live product pages
• Removal of audit history for product revisions
• Need for verification of affected deployments and inventory checks

Technical summary

The Vvveb CMS vulnerability allows low-privileged vendors to access revisions for products owned by another vendor due to inadequate access control in the admin/controller/product/revisions.php and admin/sql/sqlite/product_content_revision.sql files. This issue is fixed in version 1.0.8.4. The vulnerability could lead to unauthorized access to sensitive product content, corruption of live product pages, and removal of audit history. Defenders should prioritize patching Vvveb CMS installations to version 1.0.8.4 or later, restrict access to product revision operations, and monitor for suspicious activity related to product content modifications.

Defensive priority

Defenders should prioritize patching Vvveb CMS installations to version 1.0.8.4 or later, restrict access to product revision operations, and monitor for suspicious activity related to product content modifications.

Recommended defensive actions

• Patch Vvveb CMS installations to version 1.0.8.4 or later
• Restrict access to product revision operations
• Monitor for suspicious activity related to product content modifications
• Confirm whether affected product deployments exist in managed environments and assign an owner for follow-up
• Review the supplied official advisory or CVE record to validate affected scope, severity, and vendor guidance
• Plan vendor-supported updates or mitigations through normal change control where exposure is confirmed
• Check relevant monitoring, detection, and logs for exposed assets that need extra review

Evidence notes

The CVE record and NVD entry provide details on the vulnerability, its impact, and the fixed version. However, additional information about potential exploitation or affected deployments is limited. Defenders should verify the existence of affected product deployments in their environments, review the supplied official advisory or CVE record to validate affected scope, severity, and vendor guidance, and plan vendor-supported updates or mitigations through normal change control where exposure is confirmed. They should also review

Sources and references

Methodology and review provenance

AI-assisted synthesis based on stored public vulnerability evidence. System validation, approval state, and publication status do not by themselves establish human review of this revision. PatchSiren helps prioritize defensive review and does not prove exposure or remediation on any system.